Cargando…
NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features
The role of autoimmunity in central nervous system (CNS) disorders is rapidly expanding. In the last twenty years, different types of autoantibodies targeting subunits of ionotropic glutamate receptors have been found in a variety of patients affected by brain disorders. Several of these antibodies...
Autores principales: | Gardoni, Fabrizio, Stanic, Jennifer, Scheggia, Diego, Benussi, Alberto, Borroni, Barbara, Di Luca, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824909/ https://www.ncbi.nlm.nih.gov/pubmed/33466431 http://dx.doi.org/10.3390/cells10010077 |
Ejemplares similares
-
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies
por: Italia, Maria, et al.
Publicado: (2022) -
Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice
por: Bigini, Paolo, et al.
Publicado: (2006) -
Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity
por: Franchini, Luca, et al.
Publicado: (2020) -
Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition
por: Franchini, Luca, et al.
Publicado: (2019) -
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex
por: Stanic, Jennifer, et al.
Publicado: (2015)